| http://www.w3.org/ns/prov#value | - As an add-on therapy tometformin, it decreased the HbA1c by 0.65???1.1% [77].Vildagliptin has a good safety and tolerability profile andthe most common adverse events are unspecific (flu-likesymptoms, headache, dizziness, rarely liver enzyme eleva-tions during the initiation of therapy).
|
